Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC

NCT04459468 · clinicaltrials.gov ↗

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Lipiodol

Sponsor

University of Texas Southwestern Medical Center